Location:Room Munich, North Hall (Level 1)
The rise in clinical awareness about upper tract urothelial carcinomas (UTUCs) is in part due to the significant technological improvement in endoscopes used to examine the upper urinary tract. The development of small calibre, fibre-optic flexible digital ureteroscopes has expanded the management options for UTUC. Advances in distal-tip deflection and scope durability, combined with improved laser technology, have enhanced the role of flexible ureteroscopy from a diagnostic to a therapeutic procedure. No longer can radical nephoureterectomy (RNU) be considered the ‘gold standard’ treatment for all UTUCs.
The challenge is to identify pre-operatively which patients and tumours would be more appropriately managed in a conservative manner via endoscopic techniques and laser ablation or segmental ureterectomy in certain cases. Based on the available evidence UTUC patients with contralateral normal kidney can be classified at time of diagnosis as having “low-risk UTUC” or “high-risk UTUC”. Patients with low-risk disease should be offered (as default) endoscopic management with laser ablation and topical MMC or BCG as an option. The aim of this session is to review available data to better select UTUC suitable for kidney-sparing treatment.
- Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion. Extended presentations (*) are 3 minutes in length, followed by 3 minutes for discussion.
Institutes: 1University of Texas Md Anderson Cancer Center, Dept. of Urology, Houston, United States of America, 2University of Texas Md Anderson Cancer Center, Dept. of Pathology, Houston, United States of America, 3University of Texas Md Anderson Cancer Center, Dept. of Genetics, Houston, United States of America, 4University of Texas Md Anderson Cancer Center, Dept. of Statistics, Houston, United States of America
Institutes: 1University of Dundee, School of Medicine, Academic Section of Urology, Division of Cancer Research, Dundee, United Kingdom, 2United Lincolnshire NHS Trust, Pilgrim Hospital, Dept. of Urology, Lincolnshire, United Kingdom, 3Imperial College Healthcare NHS Trust, Charing Cross Hospital, Dept. of Urology, London, United Kingdom, 4Mid Yorkshire Hospitals NHS Trust, Dept. of Urology, Wakefield, United Kingdom, 5Leeds Teaching Hospitals NHS Trust, Dept. of Urology, Leeds, United Kingdom
Institutes: 1Tel Aviv Sourasky Medical Center, Tel-Aviv University, Dept. of Urology, Tel-Aviv, Israel, 2Stanford Health Care, Stanford University, Dept. of Urology, Stanford, United States of America, 3Tel Aviv Sourasky Medical Center, Tel-Aviv University, Dept. of Radiology, Tel-Aviv, Israel